Search

You searched for "fundus"

726 results found

Ophthalmology elective in China

2 April 2025 | | EYE - General
Wandering through the bustling streets of Zhejiang, China, immersed in the harmonious blend of modernity and tradition, I made my way to the Eye Centre of the Second Affiliated Hospital, Zhejiang University College of Medicine. The aroma of traditional Chinese...

An Inconvenient Truth: Pete’s hidden curriculum Part 4

5 June 2023 | | EYE - General
“What gets us into trouble is not what we don’t know. It’s what we know for sure that just ain’t so.” The above is a quote attributed to Mark Twain from the 2006 documentary, An Inconvenient Truth, which follows Al...

New research shows the unhealthy state of access to medicine and medical devices for blind patients

30 April 2025 | RNIB, The Safety Gap, risk assessment, diabetes, patient experience, public awareness
Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

The results of the last survey Dec21

1 December 2021 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
Consent is a hot topic at the moment and the publication of the GMC Guidance on Consent [1] has rightfully refocussed our attention on it. Consent practices vary wildly and have been the subject of many of these surveys. Once...

The writer: publishing my first book as a trainee

1 November 2014 | | EYE - Cataract, EYE - Refractive
Medicine is very hierarchical. Indeed, Hippocrates himself laid the foundation of the apprenticeship that is medical training and while it is the noble duty of the boss to pass on information and ask for tasks to be undertaken as a...

Viva Las Vegas: Dr Corey Hochman

3 August 2023 | | EYE - General
Speaking with Phoenix-based ophthalmologist and poker player, Dr Corey Hochman, Peter Cackett explores the themes of success and failure, and how the ups and downs of one’s ambition can provide an overwhelming gratitude for life. “Money won is twice as...

Advances in the understanding, diagnostic and treatment of keratoconus

1 December 2022 | | EYE - General
*Joint first authors Keratoconus is a bilateral and asymmetric eye condition in which the cornea’s structure is affected and thinned, causing a cone-shaped bulge to develop. This results in progressive loss of vision and impairs the ability of the eye...

RNIB and British Blind Sport join forces to tackle the disparity of physical activity amongst blind and partially sighted people

31 May 2023 | RNIB, British Blind Sport, See Sport Differently, exercise, charity
The UK’s leading sight loss charity, Royal National Institute of Blind People (RNIB) and British Blind Sport have joined forces to launch the See Sport Differently campaign, which aims to promote accessible sports and breakdown barriers faced by blind and partially sighted people who want to get active.

Half a million factory workers in low-income countries have vision screened in landmark project led by alliance of US Businesses

12 October 2023 | world sight day, workforce, fashion, industry, Levi Strauss, vision spring
Half a million factory workers in low-income countries have vision screened in landmark project led by alliance of US Businesses – a milestone announced today, World Sight Day.

Effective treatment for rare sight-threatening infection

1 November 2023 | Moorfields, UCL, SIFI S.p.A., Acanthamoeba, keratitis, corneal infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

Optegra launches new junior doctor training

14 December 2023 | RCOphth, private sector, public sector, Cataract surgery, training, education
Eye hospital group Optegra has further increased its support of the NHS with a new training scheme for NHS junior doctors.

LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

1 February 2024 | ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...